RFK Jr. & claimed regenerative peptides like BPC 157 The Niche BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026)